SIM
CTNM

Sandia Investment Management’s Contineum Therapeutics CTNM Stock Holding History

Sandia Investment Management’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,000
Closed -$88K – 133
2024
Q2 		$88K Buy
+5,000
New +$80.5K 0.11% 81

Other funds holding CTNM

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sandia Investment Management's CTNM Position: Q3 2024 in Review

Sandia Investment Management sold out of Contineum Therapeutics (CTNM) in Q3 2024, closing a stake of 5,000 shares — an estimated $88K sold.

Sandia Investment Management first reported a position in CTNM in Q2 2024 and held it in 1 quarter. The position peaked at $88K in Q2 2024. 52 funds tracked by Wall St. Rank hold CTNM as of Q3 2024.

  • Sandia Investment Management reported no remaining Contineum Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Sandia Investment Management sold 5,000 Contineum Therapeutics shares in Q3 2024, an estimated $88K.
  • Sandia Investment Management first reported a position in Contineum Therapeutics in Q2 2024 and held it in 1 quarter.
  • Sandia Investment Management's Contineum Therapeutics position peaked at $88K in Q2 2024.
  • 52 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2024.

Based on Sandia Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.